New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors INVESTIGATIONAL NEW DRUGS Hensley, M. L., Dizon, D., Derosa, F., Venkatraman, E., Sabbatini, P., Chi, D. S., Dupont, J., Colevas, A. D., Spriggs, D., Aghajanian, C. 2007; 25 (4): 335-341Abstract
The purpose of this study is to establish the maximum tolerated dose and define the dose-limiting toxicity of the investigational epothilone BMS-247550 in combination with fixed dose-rate gemcitabine. Patients with advanced, recurrent solid tumors who had received
View details for DOI 10.1007/s10637-007-9035-x
View details for Web of Science ID 000247275600006
View details for PubMedID 17364235